Article Details
Retrieved on: 2024-11-06 21:38:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company, focused on developing neuromodulation treatments for Obstructive Sleep Apnea (OSA), is preparing for a U.S. commercial launch upon ...
Article found on: www.webdisclosure.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here